시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 광역학 요법(PTD) 기기 시장 규모, 점유율 및 동향 분석 보고서 : 최종 용도별, 제품별, 용도별, 지역별, 전망 및 예측(2023-2030년)
Global Photodynamic Therapy Devices Market Size, Share & Trends Analysis Report By End-use, By Product (Diode Lasers, and Disposable Fiber Optic Light Delivery Devices), By Application, By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1431408
리서치사 : KBV Research
발행일 : 2024년 02월
페이지 정보 : 영문 232 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,225,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,270,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,778,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

광역학 요법(PTD) 기기 시장 규모는 2030년까지 9억 8,080만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 8.5%의 시장 성장률을 나타낼 것으로 전망됩니다.

또한, 팬데믹의 초기 단계에서 의료 분야는 일상적인 치료와 선택적 치료에 큰 혼란을 겪었습니다. 이러한 혼란은 특히 피부과 및 선택적 종양학 분야에서 PDT 기기에 대한 수요에 영향을 미쳤습니다. 팬데믹으로 인한 세계 공급망의 혼란과 제조상의 어려움은 PDT 기기를 포함한 의료기기의 가용성에 영향을 미쳤습니다. 필수 부품의 생산, 유통 및 조달 지연은 일시적으로 시장 성장을 방해했습니다. 시장에서는 의료 환경의 미생물 오염 제거와 관련된 응용 분야에서 PDT 기기에 대한 관심이 증가하고 있었습니다. 따라서 코로나19 팬데믹은 시장에 적당한 영향을 미쳤습니다.

그러나 PDT 기기 및 관련 장비를 구입하는 데 필요한 초기 투자비용은 상당할 수 있습니다. 의료 제공업체, 특히 자원이 제한된 환경에서는 높은 진입 비용으로 인해 PDT 도입이 제한될 수 있습니다. 이는 PDT의 임상 도입의 경제적 타당성에 영향을 미치며, PDT 치료에는 고가의 광증감제가 사용되며, 이는 비용이 많이 듭니다. 감광제를 포함한 소모품 비용은 PDT의 전체 비용에 추가됩니다. 제한된 상환과 높은 소모품 비용은 PDT 치료의 경제적 타당성에 부정적인 영향을 미칠 수 있습니다. 특정 지역 및 사회경제적 집단에 속한 환자들은 PDT를 사용하는 데 있어 장벽에 직면하여 의료 결과의 격차를 초래할 수 있습니다. 결과적으로, 위의 측면은 시장 성장을 저해할 수 있습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요약

제3장 시장 개요

제4장 세계 시장 : 최종 용도별

제5장 세계 시장 : 제품별

제6장 세계 시장 : 용도별

제7장 세계 시장 : 지역별

제8장 기업 개요

제9장 PDT 디바이스 시장을 위한 성공 필수 조건

LSH
영문 목차

영문목차

The Global Photodynamic Therapy Devices Market size is expected to reach $980.8 million by 2030, rising at a market growth of 8.5% CAGR during the forecast period.

PDT offers a unique advantage by selectively targeting cancer cells while sparing healthy tissues. Thus, the Cancer segment acquired $233.5 million in 2022. This targeted approach minimizes collateral damage, reduces side effects, and enhances the safety profile of the treatment. This characteristic is particularly attractive in the context of cancer management. PDT's adaptability allows it to treat both superficial and deep-seated tumors. This versatility is advantageous in addressing cancers at different stages and anatomical locations, providing a broader spectrum of applicability. Therefore, global cancer incidence is a significant driver for expanding the market.

Advancements in light sources, such as light-emitting diodes (LEDs) and lasers, contribute to more precise and efficient PDT treatments. Enhanced light delivery systems help optimize the activation of photosensitizers, allowing for better targeting of diseased cells while minimizing damage to healthy tissues. Ongoing R&D efforts focus on creating novel photosensitizers with improved selectivity, enhanced photodynamic activity, and reduced side effects. These next-generation photosensitizers contribute to the efficacy of PDT and expand its applicability across various medical specialties. Advances in optical fibers and light delivery systems contribute to improved light penetration and distribution during PDT. These enhancements enable effective treatment of deeper-seated lesions, expanding the range of applications across different medical specialties. Additionally, Combination therapies leverage the strengths of different treatment modalities to achieve synergistic effects. By combining photodynamic therapy with other interventions, such as chemotherapy or immunotherapy, healthcare providers seek to improve the overall efficacy of the treatment, leading to improved patient outcomes. PDT, when combined with other therapies, can influence the tumor microenvironment in ways that enhance the effectiveness of the overall treatment. Synergistic effects may include improved oxygenation, enhanced immune response, and modulation of signaling pathways critical for cancer cell survival. Factors such as the type and stage of cancer, genetic profile, and patient response to previous treatments can be considered in tailoring combination approaches with PDT. Thus, exploring combination therapies and synergistic approaches expands the market.

Further, during the initial phases of the pandemic, the healthcare sector saw a significant disruption in routine medical procedures and elective treatments. This disruption affected the demand for PDT devices, particularly in dermatology and elective oncology applications. The global supply chain disruptions and manufacturing challenges brought about by the pandemic impacted the availability of medical devices, including PDT devices. Delays in production, distribution, and procurement of essential components had temporarily hindered market growth. The market saw increased interest in PDT devices for applications related to microbial decontamination in healthcare settings. Therefore, the COVID-19 pandemic had a moderate impact on the market.

However, the initial investment required for acquiring PDT devices and related equipment can be substantial. For healthcare providers, especially in resource-constrained settings, the high entry cost may limit PDT adoption. This affects the economic feasibility of integrating PDT into clinical practice. PDT treatments involve the use of photosensitizing agents, which can be expensive. The cost of consumables, including photosensitizers, adds to the overall expense of PDT. Limited reimbursement and high consumable costs can negatively impact the economic viability of offering PDT treatments. Patients in certain regions or socioeconomic groups may face barriers in accessing PDT, leading to disparities in healthcare outcomes. As a result, the above aspects will cause the market growth to decline.

By End-use Analysis

By end-use, the market is classified into hospitals, clinics & dermatology centers, and others. In 2022, the hospitals segment registered the highest revenue share in the market. Several factors contribute to its significance and influence on the market dynamics. These driving factors include the increasing adoption of photodynamic therapy in hospital settings for the treatment of various medical conditions, the growing prevalence of cancer and dermatological disorders prompting the demand for effective and non-invasive treatment options, and advancements in photodynamic therapy technologies that make it a preferred choice in hospital-based interventions. In addition, the hospital segment is characterized by a high level of expertise and infrastructure, enabling the efficient implementation of photodynamic therapy procedures.

By Product Analysis

On the basis of product, the market is segmented into diode lasers and disposable fiber optic light delivery devices. The disposable fiber optic light delivery devices segment acquired a substantial revenue share in the market in 2022. The disposability of fiber optic light delivery devices provides benefits such as improved hygiene, lowered cross-contamination risks, and cost-effectiveness. The healthcare industry progressively acknowledges the practicality and effectiveness of disposable devices, fostering this market growth. Moreover, the disposable fiber optic light delivery devices sector is experiencing expansion driven by advancements in fiber optic technology and a growing demand for minimally invasive procedures. These devices address the changing requirements of healthcare professionals, delivering heightened precision in light delivery and optimizing treatment outcomes.

By Application Analysis

Based on application, the market is fragmented into cancer, actinic keratosis, acne, psoriasis, and others. In 2022, the cancer segment held the highest revenue share in the market. PDT relies on photosensitizing agents that generate reactive oxygen species when activated by light. These reactive oxygen species induce cell damage and apoptosis (programmed cell death) in the targeted cancer cells. Various photosensitizing agents are under investigation, and their properties contribute to the specificity and efficacy of PDT in cancer treatment. Researchers and clinicians are exploring the integration of PDT with other cancer treatment modalities. Combination therapies aim to enhance the overall effectiveness of cancer treatment by addressing different aspects of the disease.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region witnessed the largest revenue share in the market. This can be attributed to several aspects, including increased healthcare expenditure, the presence of certified professionals, well-established healthcare infrastructure, a concentration of key market players in the U.S., a growing demand for innovative biologics in cancer treatment, widespread adoption of photodynamic therapy, and continuous product launches by industry stakeholders. Strategic initiatives, specifically geared towards targeted cancer control and investments in advanced early detection and treatment methodologies, play a pivotal role in reducing cancer mortality rates. The rising incidence of cancer in the U.S. is expected to drive demand for treatment, thereby fueling the market expansion in the region.

List of Key Companies Profiled

Global Photodynamic Therapy Devices Market Report Segmentation

By End-use

By Product

By Application

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Photodynamic Therapy Devices Market, By End-use

Chapter 5. Global Photodynamic Therapy Devices Market, By Product

Chapter 6. Global Photodynamic Therapy Devices Market, By Application

Chapter 7. Global Photodynamic Therapy Devices Market, By Region

Chapter 8. Company Profiles

Chapter 9. Winning Imperatives of Photodynamic Therapy Devices Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기